Home › NDC Lookup › Ingredients › Lansoprazole › 55111-0399-01
💊image loading
(from DailyMed)

lansoprazole 30 mg Capsule, Delayed Release, 100-count — NDC 55111-399-01 (Billing 55111-0399-01)

by Dr. Reddy's Laboratories Limited · 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE

This is a package of 100 capsules of lansoprazole 30 mg Capsule, Delayed Release from Dr. Reddy's Laboratories Limited, marketed since Jun 2013 and currently FDA-listed.

NDC 55111-0399-01
🏷️ FDA NDC (as labeled) 55111-399-01 billing pads the product segment with a zero
This package
Contains100-count Pack sizes7 compare ↓
Also priced by: Part D plans $0.4438/unit — full pricing hub ↓
Product page 55111-0399-05 Also comes in: 10 capsules 55111-399-79 30 capsules 55111-399-30 60 capsules 55111-399-60 90 capsules 55111-399-90 500 capsules 55111-399-05 2500 capsules 55111-399-92
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Past resolved recalls for this product (2)
Class II · Mar 23, 2022 · Terminated — Failed Dissolution Specifications; during long term stability testing. (Dr. Reddy's Laboratories, Inc.) · FDA recall D-0737-2022
Class II · Mar 23, 2022 · Terminated — Failed Dissolution Specifications; during long term stability testing. (Dr. Reddy's Laboratories, Inc.) · FDA recall D-0738-2022

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 55111-399-01
Product NDC 55111-399
11-digit billing NDC 55111039901
SPL Set ID b831861d-b722-9bfe-0d9d-d9a0c4e21de6
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2013-06-20
Dosage form CAPSULE, DELAYED RELEASE
Substance LANSOPRAZOLE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 49270040006520
GPI class Lansoprazole
GCN Seq No 030107
GCN 01698
HICL code 008993
Ingredient (HICL) Lansoprazole
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4J
Therapeutic class — specific (HIC3) Proton-Pump Inhibitors
AHFS code 56:28.36.00
AHFS class Proton-Pump Inhibitors
FDB label name LANSOPRAZOLE DR 30 MG CAPSULE
FDB brand name Lansoprazole
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 030107
  • GCN: 01698
  • GPI-14 (Medi-Span): 49270040006520
  • HICL (First Databank): 008993
  • AHFS class code: 56:28.36.00
Why two NDCs? The FDA registers this code as 55111-399-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 55111-0399-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name LANSOPRAZOLE DR 30 MG CAPSULE Ingredient Lansoprazole
📗 Our plain-language guide HelloPharmacist
  • It lowers stomach acid. Prescription forms treat ulcers, GERD, erosive esophagitis and conditions with too much acid. It is also used with antibiotics for H. pylori. Over-the-count...
  • Take it once a day, before eating, usually in the morning. Swallow capsules whole. Let orally disintegrating tablets dissolve on your tongue without chewing. For over-the-counter u...
  • For heartburn, the over-the-counter label says full effect can take 1 to 4 days, though some people feel relief within 24 hours. It is not meant for instant relief.
  • The most common are diarrhea, belly pain, nausea and constipation. Call your doctor if you get a severe rash, swelling, trouble breathing, diarrhea that will not clear, or muscle s...
📖 Read our full Lansoprazole guide →
9
Nutrient depletion considerations

Lansoprazole may be associated with lower levels of 9 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Lansoprazole nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.4438 $44.38 / 100 capsules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
55111-0399-01 You're viewing this 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE — — 2010-10-15 — Active
55111-0399-05 55111-399-05 Main listing 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE $0.1061 / ea $53.05 2010-10-15 — Active
55111-0399-30 55111-399-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE $0.1061 / ea $3.18 2010-10-15 — Active
55111-0399-60 55111-399-60 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE — — 2010-10-15 — Active
55111-0399-79 55111-399-79 1 BLISTER PACK in 1 CARTON / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK — — 2010-10-15 — Active
55111-0399-90 55111-399-90 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE $0.1061 / ea $9.55 2010-10-15 — Active
55111-0399-92 55111-399-92 2500 CAPSULE, DELAYED RELEASE in 1 POUCH — — — — Active

This pack shows little to no recent Medicaid volume — the 500 capsules pack carries most fills. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 capsule, delayed release in 1 bottle.
How does this package differ from NDC 55111-0399-79?
Both are lansoprazole 30 mg Capsule, Delayed Release — the drug itself is identical. This page's package is the 100-count one, while NDC 55111-0399-79 is the 10 capsules package.
What NDC number is used to bill for this package of lansoprazole 30 mg Capsule, Delayed Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Lansoprazole 30 mg 00093-7351-56 Teva 30 capsules $0.106 AB Availability likely —
Lansoprazole 30 mg 00378-8030-05 Mylan 500 capsules $0.106 AB Availability likely —
Lansoprazole 30 mg 00904-6662-45 Major 1 capsule $0.106 AB Availability likely —
Lansoprazole 30 mg 51079-0121-08 Mylan 1 capsule $0.106 AB Availability likely —
Lansoprazole 30 mg 60687-0123-01 American 1 capsule $0.106 AB Availability likely —
Lansoprazole 30 mg 68001-0112-03 BluePoint 500 capsules $0.106 AB Availability likely —
Lansoprazole 30 mg 70700-0263-05 Xiromed 500 capsules $0.106 AB Availability likely —
Lansoprazole 30 mg 82009-0039-05 Quallent 500 capsules $0.106 AB Availability likely —
Lansoprazole 30 mg 27241-0020-03 Ajanta 30 capsules — — FDA listed —
Lansoprazole 30 mg 31722-0571-01 Camber 100 capsules — AB FDA listed —
Lansoprazole 30 mg 33342-0311-07 Macleods 30 capsules — — FDA listed —
Lansoprazole 30 mg 48433-0051-08 Safecor 1 capsule — AB FDA listed —
Lansoprazole 30 mg 50090-5180-00 A-S 30 capsules — AB FDA listed —
Lansoprazole 30 mg 50090-6154-00 A-S 30 capsules — AB FDA listed —
Lansoprazole 30 mg 50090-6830-00 A-S 90 capsules — AB FDA listed —
Lansoprazole 30 mg 50090-7651-00 A-S 90 capsules — AB FDA listed —
Lansoprazole 30 mg 51407-0324-01 Golden 100 capsules — AB FDA listed —
lansoprazole 30 mgthis 55111-0399-01 Dr. 100 capsules — — FDA listed —
Lansoprazole 30 mg 63187-0152-30 Proficient 30 capsules — AB FDA listed —
Lansoprazole 30 mg 63187-0510-30 Proficient 30 capsules — AB FDA listed —
Lansoprazole 30 mg 63629-2340-01 Bryant 500 capsules — AB FDA listed —
Lansoprazole 30 mg 63629-2341-01 Bryant 90 capsules — AB FDA listed —
Lansoprazole 30 mg 63629-2342-01 Bryant 30 capsules — AB FDA listed —
Prevacid 30 mg 64764-0046-06 Takeda 4 capsules — AB FDA listed —
Lansoprazole 30 mg 67877-0275-30 Ascend 30 capsules — AB FDA listed —
Lansoprazole 30 mg 68071-3572-04 NuCare 14 capsules — AB FDA listed —
Lansoprazole 30 mg 68071-3585-03 NuCare 30 capsules — AB FDA listed —
Lansoprazole 30 mg 68071-3870-03 NuCare 30 capsules — AB FDA listed —
Lansoprazole 30 mg 68071-5119-03 NuCare 30 capsules — AB FDA listed —
Lansoprazole 30 mg 68788-7742-01 Preferred 14 capsules — AB FDA listed —
Lansoprazole 30 mg 68788-8621-01 Preferred 14 capsules — AB FDA listed —
Lansoprazole 30 mg 70756-0807-30 Lifestar 30 capsules — AB FDA listed —
Lansoprazole 30 mg 71335-1425-01 Bryant 30 capsules — AB FDA listed —
Lansoprazole 30 mg 71335-1820-01 Bryant 30 capsules — AB FDA listed —
Lansoprazole 30 mg 72162-1976-03 Bryant 30 capsules — AB FDA listed —
Lansoprazole DR 30 mg 72189-0370-90 Direct_Rx 90 capsules — AB Discontinued —
Lansoprazole 30 mg 76420-0621-90 Asclemed 90 capsules — AB FDA listed —
Lansoprazole DR 30 mg 80425-0174-01 Advanced 30 capsules — AB FDA listed —
Lansoprazole 30 mg 82461-0713-30 Medcore 30 capsules — AB FDA listed —
Lansoprazole 30 mg 67296-2270-03 Redpharm 30 capsules — AB FDA listed —
Lansoprazole 30 mg 68788-4141-03 Preferred 30 capsules — AB FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2013
On the market since
Jun 2013
📍
2026
Currently FDA-listed
13 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDr. Reddy's Laboratories Limited
Labeler code55111
First marketedJun 2013
Product typeBulk Ingredient
Portfolio200 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
500 capsules55111-0399-05 13,115 Rx · $380,488
90 capsules55111-0399-90 8,918 Rx · $182,880
30 capsules55111-0399-30 361 Rx · $5,276
100 capsules this page55111-0399-01 No Medicaid data
60 capsules55111-0399-60 No Medicaid data
10 capsules55111-0399-79 No Medicaid data
2500 capsules55111-0399-92 No Medicaid data
Drug total (last 4 qtrs): 22,394 Rx · 860,942 units · $568,644 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Lansoprazole (matched by generic name) — the program that covers self-administered drugs. 13 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Lansoprazole. CMS lists 2 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.11M
Claims incl. refills
326.1K
Beneficiaries
241.2K
Spend / beneficiary
$46.07
Spend / claim
$34.08
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Dr. Reddy's Laboratories Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Dr. Reddy's Laboratories Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 6 other package presentations of this same product, including 10 capsules (55111-0399-79), 30 capsules (55111-0399-30), 60 capsules (55111-0399-60). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Dr. Reddy's Laboratories Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 55111-0398-01 · Dr.Reddy's 55111-0404-02 · Dr. →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.